Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 7:21 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 769–792 of 1,610 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: FLD Clear all

Conditions: Breast Cancer
Interventions: Dual-Energy Contrast-Enhanced (DECE) mammography, digital mammography; Device
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 19 Years and older · Female only
Enrollment: 128 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Acute Care Service Utilization, Mental Health Status, Physical Health Status, Housing
Interventions: Peer Support-Whole Health Coaching; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: Not listed
Enrollment: 177 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 3
States / cities: No. Little Rock, Arkansas • Palo Alto, California • Bedford, Massachusetts

Conditions: Degeneration of Cervical Intervertebral Disc
Interventions: SpinalogicTM Bone Graft Stimulator; Device
Lead sponsor: Encore Medical, L.P.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 2
States / cities: San Diego, California • White Plains, New York

Conditions: Bladder Cancer
Interventions: Specimen Ultra-High field MRI, chemotherapy, Cystectomy and Lymphadenectomy; Procedure · Drug
Lead sponsor: University of Cincinnati; Other
Eligibility: 18 Years and older
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2026
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Carotid Artery Disease, Carotid Artery Stenosis, Diabetes, Cognitive Dysfunction
Interventions: Carotid endarterectomy, Shunt; Procedure · Device
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Glioblastoma, Glial Tumor, Brain Metastases, Meningioma, Schwannoma, Pituitary Tumor
Interventions: CONVIVO system, Conventional histologic evaluation; Diagnostic Test · Other
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Histiocytosis
Interventions: Trail Making Test, Parts A & B, Brief Test of Attention, Symbol Span, Controlled Oral Word Association Test, The Hopkins Verbal Learning Test-Revised, Brief Visuospatial Memory Test-Revised, Hospital Anxiety and Depression Scale, McGill Quality of Life Scale, MR Brain Imaging, Resting state functional MRI, Functional Assessment of Cancer Therapy Cognitive Scale (FACT-Cog); Behavioral · Diagnostic Test
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2027
U.S. locations: 4
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Commack, New York + 1 more

Conditions: Parkinson Disease
Interventions: Rhythmic Auditory Stimulation (RAS); Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 89 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Depression
Interventions: Transcranial Magnetic Stimulation; Device
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 64 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Glioma
Interventions: Temozolomide and Bevacizumab; Drug
Lead sponsor: Kentuckiana Cancer Institute; Other
Eligibility: 18 Years to 75 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Compulsive Behavior, Obsessive-Compulsive Disorder
Interventions: Habit Override Practice, Transcranial Magnetic Stimulation; Behavioral · Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 55 Years
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Marijuana Impairment
Interventions: Low Dose THC Marijuana, High Dose THC Marijuana, Placebo Marijuana; Drug
Lead sponsor: Yale University; Other
Eligibility: 20 Years to 40 Years
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Breast Cancer
Interventions: Mammography; Radiation
Lead sponsor: Lunit Inc.; Industry
Eligibility: Female only
Enrollment: 240 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Skin Laxity
Interventions: Venus Freeze Diamond Polar; Device
Lead sponsor: Venus Concept; Industry
Eligibility: 25 Years to 65 Years · Female only
Enrollment: 11 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Torrance, California

Conditions: Primary Open-angle Glaucoma (POAG) Patient
Interventions: SENSIMED Triggerfish®; Device
Lead sponsor: Sensimed AG; Industry
Eligibility: 40 Years to 89 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Neuropathic Pain
Interventions: Active Transcutaneous Magnetic Stimulation, Sham Transcutaneous Magnetic Stimulation; Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: San Diego, California

Conditions: Non-Arteritic Anterior Ischemic Optic Neuropathy
Interventions: Vision Restoration Therapy (NOVAVISION); Device
Lead sponsor: Emory University; Other
Eligibility: 30 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Tourette Syndrome
Interventions: Transcranial Magnetic Stimulation (active), Transcranial Magnetic Stimulation (sham); Device
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 2
States / cities: New Haven, Connecticut • New York, New York

Conditions: Colorectal (Colon or Rectal) Cancer, Pelvic Malignancies, Oncofertility
Interventions: Uteroovarian transposition; Procedure
Lead sponsor: University of South Florida; Other
Eligibility: 18 Months to 40 Months · Female only
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Bipolar Depression Depressed Phase
Interventions: Active Low Field Magnetic Stimulation, Sham Low Field Magnetic Stimulation; Device
Lead sponsor: Mclean Hospital; Other
Eligibility: 55 Years to 85 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Belmont, Massachusetts

Conditions: Postural; Strain
Interventions: Otolaryngology stretching micro-breaks (OSMB); Behavioral
Lead sponsor: George Washington University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Stroke
Interventions: Transcranial magnetic stimulation (TMS); Device
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Hart Failure With Reduced Ejection Fraction
Interventions: EMF, Placebo; Device
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 90 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Cystic Fibrosis, Irritable Bowel Syndrome, Chronic Pain
Interventions: Use of neurostimulation device; Device
Lead sponsor: St. Louis University; Other
Eligibility: 11 Years to 18 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: St Louis, Missouri

Search by objective public record fields.

Study of Dual-energy (DE) Contrast-enhanced (CE) Digital Mammography

Homeless Veterans and Peer Whole Health Coaching

A Retrospective Study to Examine the Effect of CMF Stimulation on Primary ACDF Patients

3 Tesla MRI in Patients With Bladder Cancer

Effect of Raised CBF During CEA on Cognition in DM Patients

Evaluation of the CONVIVO System

A Study of Memory, Thinking, and Brain Imaging in Adults With Histiocytosis

Effects of RAS on Gait in PD Patients With DBS

Neurophysiologic Predictors of Outcome With rTMS Treatment of Major Depressive Disorder

A Phase II Study Of Gliadel, Concomitant Temozolomide And Radiation, Followed By Dose Dense Therapy With Temozolomide Plus Bevacizumab For Newly Diagnosed Malignant High Grade Glioma

Theta Burst Stimulation for Compulsive Behavior Non-invasive Brain Stimulation Study

Examine the Feasibility of a Standardized Field Test for Marijuana Impairment: Laboratory Evaluations

Study to Evaluate Effectiveness of Investigational Device in the Assistance of Detection and Diagnosis of Breast Cancer

Radiofrequency and Pulsed Electromagnetic Field Treatment of Skin Laxity of the Mon Pubis, Labia and Vaginal Introitus

Intraocular Pressure (IOP) Patterns in Fast Versus Slow Visual Field (VF) Progression Patients

Improving Functions in Veterans With Post-traumatic Peripheral Neuropathic Pain

Vision Restoration Therapy (VRT) to Treat Non-Arteritic Anterior Ischemic Optic Neuropathy

Transcranial Magnetic Stimulation (TMS) for Individuals With Tourette's Syndrome

Utero-ovarian Transposition in Patients With Pelvic Malignancies Undergoing Whole Pelvic Radiotherapy

LFMS: Initial Trial in Geriatric Bipolar Depression

The Impact of Intraoperative Stretching Microbreaks on Otolaryngologists

Phase-dependent Evaluation of Motor Cortex Excitability With TMS in Stroke

Magnesphere for Autonomic Alteration

Neuromodulation for Children With Cystic Fibrosis Experiencing Chronic Abdominal Pain